COOK COUNTY BUREAU OF HEALTH
SERVICES
GRANTS NEWSLETTER
Volume 6, Number 4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~April,
1998
Back Issues
Published by
OFFICE OF RESEARCH DEVELOPMENT
Hektoen Building
627 South Wood Street
Chicago, IL 60612
FAX: 312-738-3102
Karen M. Smith, PhD, Director
312-633-4940
email: kmsmith@wwa.com
Bennetta Anderson, Administrative Assistant
312-633-4941
Lillian Hampton, IRB Administrator
312-633-7792
email: lhampton@hektoen.org
Funeka Sihlali, RN, Scientific Quality Coordinator
312-572-3506
email: fsihlali@hektoen.org
|
COOK COUNTY BOARD
OF
COMMISSIONERS
John H. Stroger, Jr.,
President
|
Jerry
Butler
Allan C. Carr
Earlean Collins
John P. Daley
Gregg Goslin
Carl R. Hansen
Ted Lechowicz
Roberto Maldonado |
William R. Moran
Joseph Mario Moreno
Mike Quigley
Herbert T. Schumann, Jr.
Peter N. Silvestri
Deborah Sims
Bobbie L. Steele
Calvin R. Sutker |
COOK COUNTY BUREAU OF HEALTH
SERVICES
Ruth M. Rothstein, Chief
Affiliates
Ambulatory & Community Health Network
of Cook County
Cermak Health Services of Cook County
Cook County Department of Public Health
Cook County Hospital
Oak Forest Hospital of Cook County
Provident Hospital of Cook County
|
GRANT PROFILE: MATERNAL CHILD HEALTH-HIV INTEGRATION
PROJECT
Women and children are the often-overlooked casualties of the HIV epidemic.
This is particularly tragic since we now know that therapy with zidovudine
(ZDV) can substantially decrease the risk of mother-child HIV transmission.
If appropriate education, counseling, testing and drug therapy were available
to all pregnant women, the toll HIV takes on families would be much lower.
Since 1994 the Maternal Child Health/HIV Integration Project at Cook County
Hospital has worked to change the health care system so that these services
are universally available.
A federal "Special Project of National Significance", the Project is
headed by Mary Driscoll, RN, MPH, Director of Patient Services for the
Cook County Ambulatory and Community health Network. The program has created
a system for prevention, education, early identification and treatment
of HIV in women. It is guided by an Advisory Council composed of government
and community agency representatives, health care providers, perinatal
network administrators, advocacy groups, and HIV infected women. The Council
has helped build consensus on policy issues, especially by advocating universal
access to appropriate services instead of mandatory HIV testing of pregnant
women.
In its initial needs assessment, the Project gathered information about
providers' practices in educating pregnant women about HIV and offering
them testing, as well as their knowledge of the then-newly-discovered ZDV
therapy to reduce perinatal transmission. The findings showed a woeful
lack of knowledge about HIV prevention and therapies, very low comfort
levels when talking to women about HIV, and a disbelief that HIV was a
problem affecting this
population. Fewer than 40% of these providers discussed HIV with pregnant
women or offered an HIV test. Almost none had formal guidelines for offering
HIV testing or ZDV therapy to pregnant women.
As a result, one core strategy for the Project has been training of
providers. These programs have been highly successful, in part because
they give providers a chance to interact with women who are living with
HIV. After training, many providers state that hearing about these women's
experiences will change their own interactions with patients. To date the
Project has trained 2,342 providers in Cook County, and offered technical
assistance to another 2,000.
As effective as these programs are, however, the Project's leaders realize
that educating individual providers will not, by itself, effect swift systemic
change. The Project is also working for institutional change, in the form
of written guidelines in all hospitals for HIV education, counseling and
testing, and therapy to reduce perinatal transmission. In practice, this
has meant getting approval from the Chairs of Obstetrics and Pediatrics
at each of the 63 maternity hospitals in the region, and insuring that
these endorsements result in implementation. Currently all of the hospitals
have or are developing such formal guidelines. Since all practicing obstetricians
and pediatricians must abide by the standards of the hospitals where they
have staff privileges, the impact of this initiative should be profound.
Among the Project's other accomplishments are:
Adoption by all the region's maternity hospitals of a patient/provider
agreement which outlines the all key information a woman needs about reducing
perinatal HIV transmission.
Statewide distribution under the seal of the Illinois Department of
Public Health of a Manual for Universal Education, Counseling and Voluntary
Testing of Pregnant Women.
Participation in the Intra/Post Partum Survey of Women in all 63 area
maternity hospitals.
Care coordination for 112 pregnant women identified as HIV positive.
Development of a Community Advocacy Network for women living with HIV
who seek further formal training about HIV and reducing perinatal HIV transmission.
DO YOU HAVE A GRANT TO PROFILE? If you would like
to see the achievements of your grant-funded project profiled in this newsletter,
please send a 1 to 2 page summary, preferably on disk, to Karen Smith,
Hektoen 277, 627 S. Wood Street, Chicago, 60612.
What Happens to Your Research Application After It
Gets to NIH
[Adapted from an article in the January, 1998 Newsletter of the Cancer
Control Research Branch, National Cancer Institute]
On a major grant application receipt day, delivery trucks unload thousands
of packages containing grant applications at the loading docks of the Rockledge
2 Building, the home of the NIH Center for Scientific Review (CSR, formerly
the Division of Research Grants). Each package is opened; the application
is date-stamped and logged into the NIH database for tracking.
Over a dozen Referral Officers review the contents of some 10,000 applications
each grant cycle and, using written guidelines, decide both which study
section would be most appropriate for assessment of scientific merit and
which Institute(s) of the NIH would be most suitable to fund the application,
should it be considered sufficiently meritorious. A unique application
number is assigned to each application.
The Referral Office does consider written requests from applicants for
both study section and Institute assignments (just include a cover letter
with the application). The assignment process is a collegial one, with
interaction, when necessary, on a case-by-case basis among Referral Officers,
study section Scientific Review Administrators (SRAs), Institute program
representatives, and applicants.
Within 10 days of application assignment, a computer generated letter
is mailed to each applicant and sponsored research office, listing the
study section and potential funding Institute. Upon receipt of this notice,
applicants can question the study section assignments by contacting either
the Referral Office (301-435-0715) or the study section SRA. There are
official guidelines defining the content and boundaries of the science
reviewed in each study section, but inevitably there is overlap. A particular
application may be reviewable by a number of different study sections.
The entire assignment process may take up to six weeks. If applicants have
not received notification at that time, they should contact the Referral
Office.
As applications are assigned to a study section, a continuing process
extending over six to seven weeks, the SRA begins to read through them,
analyzing content, checking for completion, and deciding which study section
members would be best suited to review each application, or act as discussants.
Some six weeks before the study section meeting, packages are mailed
to members which include all of the applications to be reviewed at the
meeting (with the exception of those applications for which a particular
member is in conflict.) Typically, two or three members are assigned to
provide written reviews of each application, and one or two additional
members to serve as discussants.
NOTE: A chartered CSR study section is composed generally of 18 to 20
individuals, nominated by the SRA from among the active and productive
researchers in the biomedical community, to serve for multi-year terms.
[Editor's note: If you want to see who currently sits on these Study Sections,
while logged on to the World Wide Web, type in the address: gopher://gopher.nih.gov:70/11/res/studysect
] The goal is to have the group's combined knowledge span the diversity
of subject matter assigned to the study section for review. However, this
is difficult to accomplish, and the study section's membership is frequently
supplemented by temporary members and written outside opinions for any
particular meeting. In some instances, Special Emphasis Panels (SEPs) are
formed on an ad-hoc basis to review applications requiring special review
expertise, or due to special circumstances (such as when a conflict of
interest occurs).
Because of the multi-month period between submission and review of an
application, applicants often wish to submit supplementary materials. However,
each study section has policies for acceptance of such additional material
(e.g. length; time of submission). SRAs should be contacted prior to submission,
both as an alert for the SRA, and to ascertain acceptable content and format.
One week before the convening of a study section, the SRA solicits,
from all members, a list of applications believed not to rank in the top
half for scientific merit. The individual lists are coalesced, and a final
list is established at the outset of the study section meeting. Those applications
in the lower half are considered to be "streamlined". They are not scored
or discussed at the meeting, but summary statements are provided, and the
applicants may subsequently revise and resubmit the application. "Streamlining"
is not equivalent to disapproval, but rather represents a decision by the
study section that the application would not rank in the top half of applications
under review during that particular meeting.
With some minor variations, all regular CSR study section meetings follow
the same format. The meetings usually last two to three days. Members convene
around a conference table to maximize interaction. The chairperson (a member
of the study section) and the SRA sit together and are responsible for
jointly conducting the meeting. Observers (program representatives or other
staff from the various NIH Institutes) may attend, but must sit in chairs
set back from the conference table and do not participate in the discussions.
The order in which the applications are reviewed can vary. Sometimes,
applications may be discussed in alphabetical (or reverse alphabetical)
order of applicant, sometimes by numerical order (oldest or newest grant
first), sometimes grouped for discussion by Institute (AA, AG, AI, CA,
etc.) or by funding mechanism (e.g. R01, R29, R21, etc.).
After the assigned reviewers and discussants provide their evaluations,
any outside opinions are read. After general discussion, members mark their
priority scores privately for each application on scoring sheets provided
by the SRA. These sheets are collected by the SRA or an administrative
assistant at the conclusion of the meeting.
Within a few days after the meeting, all priority score information
has been entered into the application database. Computer generated priority
scores and percentiles are then automatically mailed to applicants.
Feedback to applicants is important. However, it still requires six
to eight weeks to generate an average of 80 summary statements. Once those
summary statements are produced and transmitted to the appropriate NIH
Institute for funding consideration, the SRA's control over the review
of those applications ends, and his attention turns to the next grant application
cycle. At this junction, it is the Institute program officials who become
the applicant's link to the NIH with regard to the interpretation of the
reviews and the disposition of the application.
There is a flow to the review process, repeated cycle after cycle. For
example, applications submitted for the October/November receipt dates
will be assigned to CSR study sections by early December, and sent out
to members of the study section for scientific review in late
December/January.
Study sections meet between mid-February and mid-March, and summary
statements are prepared by late April/May. Institute Advisory Councils,
the second step in NIH peer review, meet in May/June to consider the study
sections' recommendations, and successful applicants can begin to receive
funding several months later.
Back to top
SEMINARS, CONFERENCES, WORKSHOPS, ETC
[A long-term calendar showing most of the major academic medical society
meetings can be found on the web at: http://www.aamc.org/meetings/mjmtgcal.htm]
STRATEGIES IN THE HEALTH CARE MARKET: THE PROFESSIONAL ASSOCIATION EXPERIENCE
will be presented by the Chicago Health Policy Research Council, May 15.
Call 773-702-4335 for more information.
PARTNERSHIPS FOR PREVENTING VIOLENCE SIX-PART SATELLITE TRAINING PROGRAM
will start May 13 at various sites around the country , including Chicago.
For more information call 888-525-6238, or go to http://www.mcet.edu/partnerships
CONTEMPORARY CHALLENGES IN HEALTH CARE ETHICS INTENSIVE BIOETHICS COURSE,
sponsored by the Kennedy Institute of Ethics, will be held June 6-11 in
Washington, DC. Call 202-687-8089 for more information.
CLINICAL TRIALS DESIGN, ANALYSIS, AND DISSEMINATION OF RESULTS will
be offered June 11-12 in Baltimore, by the Center for Clinical Trials of
Johns Hopkins Medical Institutions. For more information call 410-955-2959.
METHOD IN BIOETHICS PHILOSOPHY, LAW NARRATIVE is a Midwest Intensive
Bioethics Course to be held at Northwestern, July 13-18. Call 414-456-4299
for more information.
CONTEMPORARY ISSUES IN BEHAVIORAL AND BIOMEDICAL RESEARCH, sponsored
by the Office of Protection from Research Risks will take place in Los
Angeles July 30-31.
Office of Research Development Workshops
These workshops are open to any County-affiliated investigator or grant-seeker.
Enrollment for some sessions is limited, so please register only for those
you will be able to attend.
Grant Writing Seminar:
Gives an overview of the entire process of developing a project
and applying for funding. Includes information on approaching both governmental
and private funders, describes an approach to developing grant budgets,
discusses stylistic and content issues that are frequent stumbling blocks
in writing grant applications.
Constructing a Grant Budget:
Covers many of the technical aspects of developing an accurate
time line and budget for a grant proposal.
What Are All These Forms? Interacting With the Scientific Committee:
Gives an orientation to procedures -- and the associated forms
-- used by the Scientific Committee to
ensure that patients are protected from undue risks in research. The
Bureau forms will be discussed, and new policies and changes in federal
regulations will be covered.
To register for any of these, call Bennetta Anderson at 312-633-4941.
If you would like to schedule one or more of these workshops in your Department
or at another site, please call Karen Smith at 633-4940.
Back to top
FUNDING OPPORTUNITIES
National Institutes of Health:
All NIH announcements from the past several years, including full
text versions of RFA's and PA's, can be reached on the web at: http://grants.nih.gov/grants/guide/index.html
To have the NIH Guide sent automatically to your e-mail address every
week, click on the LISTSERV link on this page and follow the instructions.
To ask specific questions about NIH grant programs, send e-mail to:
grantsinfo@nih.gov
NIH RFA'S AND RFP'S:
These are one time only opportunities. Call 312-633-4940 to check
for due dates or to get copies of full announcements
SEXUALLY TRANSMITTED DISEASES COOPERATIVE RESEARCH CENTERS (RFA AI-98-007)National
Institute of Allergy and Infectious Diseases
CHEMOPREVENTION IN GENETICALLY-IDENTIFIED HIGH-RISK GROUPS: INTERACTIVE
RESEARCH AND DEVELOPMENT PROJECTS (RFA CA-98-012)National Cancer Institute
FAMILY AND CHILD WELL-BEING RESEARCH NETWORK (RFA HD-98-009) National
Institute of Child Health and Human Development
CANCER DRUG DISCOVERY: DIVERSITY GENERATION AND SMART ASSAYS (RFA CA-98-009)
National Cancer Institute
CLINICAL RESEARCH CURRICULUM AWARD (RFA OD-98-007) National Institutes
of Health
ASTHMA AND ALLERGIC DISEASES RESEARCH CENTERS (RFA AI-98-005) National
Institute of Allergy and Infectious Diseases
CHRONIC FATIGUE SYNDROME COOPERATIVE RESEARCH CENTERS (RFA AI-98-008)
National Institute of Allergy and Infectious Diseases
RESEARCH ON TOPICAL MICROBICIDES FOR PREVENTION OF STDS/HIV (RFA AI-98-011)
National Institute of Allergy and Infectious Diseases
CELLULAR AND MOLECULAR INTERRELATIONSHIPS OF ATHEROSCLEROSIS AND HYPERTENSION
(RFA: HL-98-009) National Heart, Lung, and Blood Institute
DECREASING WEIGHT GAIN IN AFRICAN-AMERICAN PREADOLESCENT GIRLS - FIELD
AND COORDINATING CENTERS (RFA HL-98-010) National Heart, Lung, and Blood
Institute
STRATEGIES TO AUGMENT ALVEOLIZATION (RFA HL-98-011) National Heart,
Lung, and Blood Institute
SILVIO O. CONTE DIGESTIVE DISEASES RESEARCH CORE CENTERS (RFA DK-98-016)
National Institute of Diabetes and Digestive and Kidney Diseases
RESEARCH STUDIES ON MICROBIOLOGICAL HAZARDS ASSOCIATED WITH THE FOOD
ANIMAL PRODUCTION ENVIRONMENT, INCLUDING ANIMAL FEEDS (RFA FDA-CVM-98-1)
Food and Drug Administration
EFFECTIVENESS OF TREATMENT FOR ADOLESCENTS WITH MAJOR DEPRESSION (RFP
NIMH-98-DS-0008) National Institute of Mental Health
NIMH PSYCHOACTIVE DRUG SCREENING PROGRAM (RFP NIMH-98-DB-0005) National
Institute of Mental Health
PEDIATRIC BRAIN MRI DATABASE AND STUDY OF NORMAL DEVELOPMENT: CENTRAL
COORDINATING SITE (RFP NIMH-98-DM-0002) National Institute of Mental Health,
National Institute of Neurological Disorders and Stroke, National Institute
of Child Health and Human Development
INFORMATICS FOR THE NATIONAL HEART ATTACK ALERT PROGRAM (RFP NLM-98-103/EAS)
National Library of Medicine
BEHAVIORAL STRATEGIES IN CHILDREN AND ADOLESCENTS TO PREVENT OSTEOPOROSIS
LATER IN LIFE (RFA HD-98-008) National Institute of Child Health and Human
Development
MENTAL RETARDATION RESEARCH CENTERS (RFA HD-98-010) National Institute
of Child Health and Human Development
BASIC BIOBEHAVIORAL RESEARCH ON CANCER-RELATED BEHAVIORS (RFA CA-98-015)
National Cancer Institute
CLINICAL NUTRITION RESEARCH UNIT CORE CENTERS (RFA DK-98-013) National
Institute of Diabetes and Digestive and Kidney Diseases
CENTERS OF EXCELLENCE IN MOLECULAR HEMATOLOGY (RFA DK-98-015) National
Institute of Diabetes and Digestive and Kidney Diseases
INTERNATIONAL TRAINING IN MEDICAL INFORMATICS (RFA TW-98-003) Fogarty
International Center, National Library of Medicine
STUDY OF EFFICACY OF GLUCOSAMINE AND CHONDROITIN SULFATE IN OSTEOARTHRITIS
(RFP NIH-NIAMS-98-2) National Institute of Arthritis and Musculoskeletal
and Skin Diseases
DEVELOPMENTAL GRANT: ENVIRONMENTAL HEALTH SCIENCES CENTERS (RFA ES-98-004)
National Institute of Environmental Health Sciences
IMPLEMENTATION OF THE NATIONAL OCCUPATIONAL RESEARCH AGENDA (RFA OH-98-044)
National Institute for Occupational Safety and Health, CDC, National Institute
of Arthritis and Musculoskeletal and Skin Diseases, National Institute
of Environmental Health Sciences, National Heart, Lung, and Blood Institute,
National Institute on Aging
UNITED STATES RENAL DATA SYSTEM COORDINATING CENTER: SPECIAL STUDIES
CENTERS (RFP NIH-NIDDK-98-7) National Institute of Diabetes and Digestive
and Kidney Diseases
UNITED STATES RENAL DATA SYSTEM: SPECIAL STUDIES CENTERS (RFP NIH-NIDDK-98-8)
National Institute of Diabetes and Digestive and Kidney Diseases
NIMH GENETICS COORDINATING CENTER (RFP NIH-NIMH-98-DB-0004) National
Institute of Mental Health
TREATMENT FOR BIPOLAR DISORDER (RFP NIH-NIMH-98-DS-0001) National Institute
of Mental Health
BRAIN MOLECULAR ANATOMY PROJECT: FEASIBILITY STUDIES (RFP NIH-NIMH-98-DB-0010)
National Institute of Mental Health
NETWORK ON ANTIMICROBIAL RESISTANCE IN STAPHYLOCOCCUS AUREUS (RFP NIH-NIAID-DMID-98-24)National
Institute of Allergy and Infectious Diseases
Back to top
NIH PROGRAM ANNOUNCEMENTS
(PA'S): These are ongoing funding priorities, with due dates usually
October 1, February 1 and June 1 of each year. Note that HIV-related applications
are due January 2, May 1 and September. Past PA's, many of which are still
open, can be searched at the NIH
Guide web site.
HEALTH-CARE ENCOUNTERS BETWEEN ELDERLY PATIENTS, PHYSICIANS, AND OTHER
CARE PROVIDERS (PA-98-059) National Institute on Aging, National Institute
of Nursing Research
DEVELOPMENTAL PROCESSES IN DIFFERENTIAL EXPRESSION OF GLOBIN GENES (PAS-98-060)
National Institute of Diabetes and Digestive and Kidney Diseases, National
Heart, Lung, and Blood Institute
INDIVIDUAL MENTORED RESEARCH SCIENTIST DEVELOPMENT AWARD IN GENOMIC
RESEARCH AND ANALYSIS (PAR-98-061) National Human Genome Research Institute
INSTITUTIONAL MENTORED RESEARCH SCIENTIST DEVELOPMENT AWARD IN GENOMICS
RESEARCH AND ANALYSIS (PAR-98-062) National Human Genome Research Institute
CURRICULUM DEVELOPMENT AWARD IN GENOMIC RESEARCH AND ANALYSIS (PAR-98-063)
National Human Genome Research Institute
MENTORED CLINICAL SCIENTIST AWARDS IN NEPHROLOGY (PAR-98-064) National
Institute of Diabetes and Digestive and Kidney Diseases, National Kidney
Foundation
STATISTICAL METHODS IN HIV/AIDS RESEARCH (PA-98-054) National Institute
of Allergy and Infectious Diseases, National Institute of Mental Health
CORE GRANT FOR ENHANCING NEUROSCIENCE TRANSLATION (PAR-98-055) National
Institute of Mental Health
SILVIO O CONTE FEASIBILITY CENTERS FOR NEUROSCIENCE RESEARCH (PAR-98-056)
National Institute of Mental Health
SILVIO O. CONTE CENTERS FOR NEUROSCIENCE RESEARCH (PAR-98-057) National
Institute of Mental Health
SILVIO O CONTE CENTERS FOR THE NEUROSCIENCE OF MENTAL DISORDERS (PAR-98-058)
National Institute of Mental Health
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AWARD (PA-98-052)
All Institutes
MIDCAREER INVESTIGATOR AWARD IN PATIENT-ORIENTED RESEARCH
(PA-98-053) All Institutes
RESEARCH ON MOLECULAR IMMUNOLOGY OF STDs (ROMIS) (PA-98-051) National
Institute of Allergy and Infectious Diseases
OTHER OPPORTUNITIES
Various deadlines starting November 2
RESEARCH ON AGING, American Federation for Aging Research (212-752-2327)
Various deadlines
ASSISTANCE FOR VICTIMS OF CRIME, Office for Victims of Crime (800-627-6872,
or http://www.ojp.usdoj.gov/ovc/new)
Open
CENTER ON CRIME, COMMUNITIES & CULTURE, Open Society Institute
(212-548-0135, or http://www.soros.org/crime)
Open
ALCOHOL & DRUG DEPENDENCE, Smithers Foundation (516-676-0067)
Open
DRUNK DRIVING PREVENTION, Allstate Foundation (2775 Sanders Rd., Ste
F3, Northbrook, IL 60062-6127)
Open
SUBSTANCE ABUSE PREVENTION & EDUCATION, JM Foundation (60 East
42nd St, Ste 1651, New York, NY)
Open
PROGRAMS FOR WOMEN & GIRLS, Ms. Foundation (212-742-2300)
June 26
STATE-WIDE LEAD HAZARD AWARENESS, Housing and Urban Development (800-HUD-8929
or http://www.hud.gov)
June 29
ALZHEIMER'S DISEASE CAREGIVING OPTIONS, Administration on Aging (202-619-1269
announcement # AoA-98-6)
October 15
JACOBS INSTITUTE-ORTHO-MCNEIL PHARMACEUTICAL SCHOLAR IN WOMEN'S HEALTHCARE,
Jacobs Institute (202-863-4990)
August 1 and February 1
NUTRITION AND HUNGER, Quaker Oats Foundation (312-456-3048)
May 18, letter of intent; July 20, full application
HIV/STD/TB RESEARCH, Centers for Disease Control and Prevention (404--639-0902,
announcement #98023, or http://www.cdc.gov)
June 8
RECOVERY COMMUNITY SUPPORT PROGRAM, Substance Abuse and Mental Health
Services Administration (301-443-3820, http://www.samhsa.gov)
June 8
DRUG ABUSE RECOVERY AND TREATMENT PROGRAMS: METHAMPHETAMINE TREATMENT;
CHILDREN OF SUBSTANCE ABUSING PARENTS; PARENTING ADOLESCENTS, Substance
Abuse and Mental Health Services Administration (http://www.samhsa.gov)
June 10 (pre-application)
PEDIATRIC AIDS, Elizabeth Glaser Scientist Award (310-395-9051, or
http://www.pedaids.org)
June 19
PROJECT: YOUTH CONNECT, Substance Abuse and Mental Health Services
Administration (301-443-9104, or http://www.samhsa.gov)
June 19
MENTAL HEALTH SUBSTANCE ABUSE SERVICES FOR OLDER ADULTS, Substance
Abuse and Mental Health Services Administration ( 301-443-5850, or http://www.samhsa.gov)
July 1
OCCUPATIONAL SAFETY AND HEALTH EDUCATION PROGRAMS, Centers for Disease
Control and Prevention (513-523-8241, announcement #98045, or http://www.cdc.gov)
September 10
OUTCOMES RESEARCH, American Digestive Health Foundation (301-654-2635,
or http://www.gastro.org/adhf.html)
Various deadlines, starting May 13 for pre-proposal
BREAST CANCER RESEARCH, US Army Medical Research and Development Command
(301-619-7079, or http://mrmc-rad6.army.mil/documents.html)
October 1
YOUNG INVESTIGATOR PROGRAM, Office of Naval research 9703-696-4111,
refer to BAA 98-013, or http://www.onr.navy.mil)
June 8
EXEMPLARY TREATMENT MODELS FOR ADOLESCENTS, Substance Abuse and Mental
Health Services Administration (301-443-6574, or http://www.samhsa.gov)
June 1
RESEARCH ON VIOLENCE AGAINST WOMEN: SYNTHESES FOR PRACTITIONERS, National
Institute of Justice (800-851-3420, or http://www.ncjrs.org/fedgrant.htm#nij)
LOST A LINK?
Look in the alphabetical index to links on this
site
|
